Between 2 and 7 September 2026, MBK Partners put roughly 470 billion won ($349 million) into two Korean beauty assets. One is a control buyout of Skin Idea and Life&Bio at about 300 billion won ($223 million), near eight times combined EBITDA. The other is 172 billion won ($128 million) for 40% of AXIS-Y's parent at a 430 billion won ($320 million) valuation, founder still in control. Korea's largest buyout firm bought the cash and the option at once, and has not decided whic

Lisa Price founded Carol’s Daughter in her Brooklyn kitchen to meet an ignored need: nourishing natural Black hair. Driven by authenticity and celebrity investment, the brand exploded—yet struggled with manufacturing limits and high retail costs, leading to bankruptcy. Acquired by L’Oréal in 2014, the brand gained corporate structure and efficiency. Now reclaimed by Price in 2025, it enters a new chapter balancing indie heart with CEO discipline.

LG Household & Health Care agreed to sell Avon North America to Regent affiliate Stratford Worldwide for $6M—a sharp drop from the $330M invested since 2019 ($125M purchase + $205.5M loan). The low price doesn't mark the death of direct selling, as model expansion elsewhere shows. Instead, it reveals that a brand name and its underlying representative seller network are separate assets, with real value lying in the distribution machine itself.

Estée Lauder wrote USD 375 million off Dr.Jart+ in fiscal 2025, then ran a sale process for the brand, took bids, and decided in July 2026 to keep it and shrink the team instead. The company's fiscal 2026 results, published on 19 August 2026, name Dr.Jart+ in exactly two places. This is the clearest public record of what happens to a Korean brand after the exit everyone treats as the finish line.

On 18 August, CVC Capital Partners subscribed KRW 300bn of new Silicon2 shares at a premium, taking 9.23% of a company that owns no beauty brand at all. Six months earlier, Goodai Global had bought the distributor Hansung USA to take its North American supply chain in-house. This piece reads the two deals as the same structural problem solved from opposite ends, and sets out what the aggregator model actually leaves a Korean brand holding.

Beiersdorf's €100 million media boost for NIVEA contrasts with H1 2026 results where sell-out growth remained positive despite a 6.8% organic decline. Meanwhile, APR achieved a 24.8% operating margin, outperforming Amorepacific (9.8%) and LG Household & Health Care (6.2%). The data suggests true brand value stems from what a product can prove, while stories only distribute it.

Korean cosmetics exports surged 27.3% in H1 2026 to reach $7 billion, but the real value is shifting from consumer-facing brands to the supply chain. While high-profile brand acquisitions face earnings squeezes, infrastructure players like packaging specialist Samhwa and ingredient distributor Woojin Trading are commanding massive private equity returns and strategic buyouts. The smart capital is betting on the unglamorous layer that supplies every winner.

Amorepacific's plant sale and LG H&H's beverage unit auction signal a major strategic pivot during a record K-beauty export boom. While trimming underperforming assets improves capital efficiency, it misses the core challenge: legacy beauty giants are falling behind nimble indie brands like APR. To regain leadership, conglomerates must look beyond acquiring new brands and leverage their true advantage—decades of heritage and story.

How does a scooter enthusiast build a $75M beauty empire? Discover the data-driven strategies and 'niche moat' tactics Chang-jun Baek used to transform Elleven Corporation into a K-Beauty powerhouse.